Among the rest filtered genes, we noticed that 20% (10/50 in T-ALL), 25.9% (27/104 in CLL), 43.8% (39/89 in AML), and 16.3% (9/55, in CML) were even in the opposite association direction with GATA3 to that in ALL (Supplementary Table 4). This evidence concerns the gene GATA3 and chronic myelogenous leukemia, BCR-ABL1 positive.